Education
About Us
Working with TipRanks
Follow Us
Exagen Inc (XGN)
NASDAQ:XGN
Earnings Data
Report Date
Nov 18, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.16Last Year’s EPS
-0.28Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for Exagen, marked by record revenue growth, successful biomarker launches, and strategic leadership additions. While there are challenges related to operating losses and increased expenses, the company's strong cash position and positive revenue guidance indicate resilience and growth potential.Company Guidance
Record Revenue Achieved
Exagen reported Q2 revenue of $17.2 million, marking a 14% year-over-year growth and the highest quarterly revenue in company history.
Significant Per Territory Revenue Growth
Average revenue per territory reached over $430,000, a 50% increase from two years ago, reflecting strong commercial leverage.
Successful Biomarker Launch
The launch of novel T cell and RA markers has significantly enhanced commercial discussions and clinical adoption.
Expansion of R&D and Leadership
Exagen made two significant hires: Dr. Michael Mahler as Chief Scientific Officer and Chas McKhann to the Board of Directors, enhancing the company's scientific credibility and strategic direction.
Strong Cash Position
The company ended the quarter with over $30 million in cash and equivalents, with a path towards neutral operating cash flow.
Positive Revenue Guidance
Exagen provided a full-year revenue guidance of between $65 million and $70 million, with expectations of positive adjusted EBITDA in Q4.
XGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
XGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 29, 2025 | $7.39 | $8.45 | +14.34% |
May 05, 2025 | $6.02 | $6.25 | +3.82% |
Mar 11, 2025 | $2.85 | $3.37 | +18.25% |
Nov 12, 2024 | $2.97 | $2.79 | -6.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Exagen Inc (XGN) report earnings?
Exagen Inc (XGN) is schdueled to report earning on Nov 18, 2025, After Close (Confirmed).
What is Exagen Inc (XGN) earnings time?
Exagen Inc (XGN) earnings time is at Nov 18, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is XGN EPS forecast?
XGN EPS forecast for the fiscal quarter 2025 (Q3) is -0.16.